<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38636655</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-2990</ISSN><JournalIssue CitedMedium="Internet"><Volume>368</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The American journal of the medical sciences</Title><ISOAbbreviation>Am J Med Sci</ISOAbbreviation></Journal><ArticleTitle>Association of pulmonary function test abnormalities and quality-of-life measures after COVID-19 infection.</ArticleTitle><Pagination><StartPage>112</StartPage><EndPage>121</EndPage><MedlinePgn>112-121</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjms.2024.04.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9629(24)01170-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long-COVID is a multisystem disease that can lead to significant impairments in health-related quality of life (HRQoL). Following COVID-19 infection, abnormalities on pulmonary function tests (PFT) are common. The primary aim of this study is to evaluate for any correlation between PFT abnormalities and impairment in HRQoL scores following COVID-19 infection.</AbstractText><AbstractText Label="METHODS">This is an analysis of a prospective cohort of patients in Louisville, KY who were infected with COVID-19. Data collected included demographics, past medical history, laboratory tests, PFTs, and several HRQoL questionnaires such as the EuroQol 5 Dimension HRQoL questionnaire (EQ-5D-5 L), Generalized Anxiety Disorder 7 (GAD-7), Patient Health Questionnaire (PHQ-9), and Posttraumatic stress disorder checklist for DSM-5 (PCL-5). Descriptive statistics were performed, comparing PFTs (normal vs abnormal) and time since COVID-19 infection (3- vs 6- vs &#x2265; 12 months).</AbstractText><AbstractText Label="RESULTS">There were no significant differences in FEV1, FVC, or the percentage of patients with abnormal PFTs over time after COVID-19 infection. Following COVID-19, patients with normal PFTs had worse impairment in mobility HRQoL scores and change in GAD-7 scores over time. There were no differences over time in any of the HRQoL scores among patients with abnormal PFTs.</AbstractText><AbstractText Label="CONCLUSIONS">Among patients with an abnormal PFT, there was no temporal association with HRQoL scores as measured by EQ-5D-5 L, GAD-7, PHQ-9, and PCL-5. Among patients with a normal PFT, mobility impairment and anxiety may be associated with COVID-19 infection. Following COVID-19 infection, impairment in HRQoL scores is not completely explained by the presence of abnormalities on spirometry.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bradley</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care Medicine and Sleep Disorders, Department of Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY, USA; Biometrics and Data Science, Fosun Pharma, Beijing, 100026, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touloumes</LastName><ForeName>Nikolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lusciks</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>T'shura</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, KY, USA; Department of Epidemiology and Population Health, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Emma C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Trinity College of Arts and Sciences, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghafghazi</LastName><ForeName>Shahab</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Forest W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Maiying</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jiapeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallazzi</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care Medicine and Sleep Disorders, Department of Medicine, University of Louisville, Louisville, KY, USA. Electronic address: r0cava01@louisville.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Center of Excellence for Research in Infectious Diseases (CERID) Post-COVID-19 Research Clinic Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES030283</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI172873</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL158779</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U18 TR003787</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Sci</MedlineTA><NlmUniqueID>0370506</NlmUniqueID><ISSNLinking>0002-9629</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="Y">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Long-covid</Keyword><Keyword MajorTopicYN="N">Pulmonary function tests</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList><CoiStatement>Declaration of competing interest This work was supported by Gilead Sciences COMMIT COVID-19 RFP Program [grant number IN-US-983&#x2013;6063]; National Center For Advancing Translational Sciences [grant number U18TR003787]; National Institute of Environmental Health Sciences [grant number P30 (P30ES030283)]; National Heart, Lung and Blood Institute 1R01HL158779&#x2013;01; National Institute of Allergy and Infectious Diseases 1R01AI172873&#x2013;01. Otherwise, all authors declare no other conflicts of interest in relation to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>19</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38636655</ArticleId><ArticleId IdType="mid">NIHMS1990867</ArticleId><ArticleId IdType="pmc">PMC11269026</ArticleId><ArticleId IdType="doi">10.1016/j.amjms.2024.04.010</ArticleId><ArticleId IdType="pii">S0002-9629(24)01170-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep 2022;12(1):3369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021;27(10):1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR,et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 2022;400(10350):452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 2022;54(1):1473&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, et al. Post-acute COVID-19 syndrome. Nat Med 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J, Blau H, et al. Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs. medRxiv 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 2022;32(4):e2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Ben&#xed;tez ID, et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest 2021;160(1):187&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J 2021;57(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco JR, Cobos-Ceballos MJ, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect 2021;27(6):892&#x2013;896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920814</ArticleId><ArticleId IdType="pubmed">33662544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Yim JJ, et al. Pulmonary function and chest computed tomography abnormalities 6&#x2013;12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res 2022;23(1):233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9446643</ArticleId><ArticleId IdType="pubmed">36068582</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, et al. European Respiratory Society statement on long COVID follow-up. Eur Respir J 2022;60(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario P, De Marzo V, et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol 2021;340:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302817</ArticleId><ArticleId IdType="pubmed">34311011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Chen R, et al. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J 2021;57(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7758779</ArticleId><ArticleId IdType="pubmed">33361097</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneroni M, Simonelli C, et al. Muscle Strength and Physical Performance in Patients Without Previous Disabilities Recovering From COVID-19 Pneumonia. Am J Phys Med Rehabil 2021;100(2):105&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">33181531</ArticleId></ArticleIdList></Reference><Reference><Citation>Havers FP, Pham H, et al. COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022. JAMA Intern Med 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9459904</ArticleId><ArticleId IdType="pubmed">36074486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng OT, Marimuthu K, et al. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore. JAMA Netw Open. 2022;5(8):e2228900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9419014</ArticleId><ArticleId IdType="pubmed">36018588</ArticleId></ArticleIdList></Reference><Reference><Citation>Feikin DR, Higdon MM, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 2022;399(10328):924&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863502</ArticleId><ArticleId IdType="pubmed">35202601</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 2022;28(8):1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A, Kalleberg KT, et al. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS One. 2021;16(8):e0256142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389372</ArticleId><ArticleId IdType="pubmed">34437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020;55(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, et al.. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021;76(4):399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis KL, Helgeson SA, et al. COVID-19 and the effects on pulmonary function following infection: A retrospective analysis. EClinicalMedicine. 2021;39:101079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360709</ArticleId><ArticleId IdType="pubmed">34405138</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med 2022;10(9):863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaso AW, Tesema HG, et al. Health-Related Quality of Life and Associated Factors Among Covid-19 Survivors. Experience from Ethiopian Treatment Centers. Infect Drug Resist 2022;15:6143&#x2013;6153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9593469</ArticleId><ArticleId IdType="pubmed">36304968</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020;81(6):e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab-Zozani M, Hashemi F, et al. Health-Related Quality of Life and its Associated Factors in COVID-19 Patients. Osong Public Health Res Perspect 2020;11(5):296&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577388</ArticleId><ArticleId IdType="pubmed">33117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Meys R, Delbressine JM, et al. Generic and Respiratory-Specific Quality of Life in Non-Hospitalized Patients with COVID-19. J Clin Med 2020;9(12).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764406</ArticleId><ArticleId IdType="pubmed">33317214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellemons ME, Huijts S, et al. Persistent Health Problems beyond Pulmonary Recovery up to 6 Months after Hospitalization for COVID-19: A Longitudinal Study of Respiratory, Physical, and Psychological Outcomes. Ann Am Thorac Soc 2022;19(4):551&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8996273</ArticleId><ArticleId IdType="pubmed">34582728</ArticleId></ArticleIdList></Reference><Reference><Citation>Admon AJ, Iwashyna TJ, et al. Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months. JAMA Netw Open. 2023;6(2):e2255795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9929698</ArticleId><ArticleId IdType="pubmed">36787143</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019;95:103208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20(10):1727&#x2013;1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, et al. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Blevins CA, Weathers FW, et al. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015;28(6):489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">26606250</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. https://www.R-project.org/.Published 2022. Accessed2022.</Citation></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, et al. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract 2022;39(1):159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra S, Carsin AE, et al. Health-related quality of life and risk factors associated with spirometric restriction. Eur Respir J 2017;49(5).</Citation><ArticleIdList><ArticleId IdType="pubmed">28546266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheaton AG, Ford ES, et al.. Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States--National Health and Nutrition Examination Survey 2007&#x2013;2010. BMC Public Health. 2013;13:854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848467</ArticleId><ArticleId IdType="pubmed">24040892</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakshbandi G, Moor CC, et al. Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN&#x2019; study. Respirology. 2022;27(7):501&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115460</ArticleId><ArticleId IdType="pubmed">35441433</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson CL, Higgins AM, et al. Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness. Am J Respir Crit Care Med 2022;205(10):1159&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9872799</ArticleId><ArticleId IdType="pubmed">35258437</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K, Townsend L, et al. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study. Respir Res 2022;23(1):115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9067558</ArticleId><ArticleId IdType="pubmed">35509060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun 2022;13(1):5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund O, Breslavsky A, et al. Assessment of a close respiratory follow-up schedule at 3 and 6 months after acute COVID-19 and its related investigations. Respir Med 2023;217:107367.</Citation><ArticleIdList><ArticleId IdType="pubmed">37479120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F, M&#xe9;ar L, et al. The protein expression profile of ACE2 in human tissues. Mol Syst Biol 2020;16(7):e9610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Morone G, Palomba A, et al. Incidence and Persistence of Viral Shedding in COVID-19 Post-acute Patients With Negativized Pharyngeal Swab: A Systematic Review. Front Med (Lausanne). 2020;7:562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483760</ArticleId><ArticleId IdType="pubmed">32984389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, Xu SB, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020;133(9):1039&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147278</ArticleId><ArticleId IdType="pubmed">32118639</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Neto AN, Monteiro RAA, et al. Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy. Histopathology. 2020;77(2):186&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280721</ArticleId><ArticleId IdType="pubmed">32443177</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Jin M, et al. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Netw Open. 2020;3(5):e208292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206502</ArticleId><ArticleId IdType="pubmed">32379329</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmakaty I, Ferih K, et al. Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports. Cells. 2022;11(20).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9600635</ArticleId><ArticleId IdType="pubmed">36291083</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ, Pogue A, et al. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol Neurobiol 2022;42(1):217&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi S, Srivastava AK, et al. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? ACS Chem Neurosci 2020;11(10):1379&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pubmed">32348111</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Bai WZ, et al. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92(6):552&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, Cao J, et al. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res 2022;32(1):24&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8617373</ArticleId><ArticleId IdType="pubmed">34837059</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Mentzer SJ, et al. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021;24(4):755&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238037</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId></ArticleIdList></Reference><Reference><Citation>Grillo F, Barisione E, et al.. Lung fibrosis: an undervalued finding in COVID-19 pathological series. Lancet Infect Dis 2021;21(4):e72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386839</ArticleId><ArticleId IdType="pubmed">32735785</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsana L, Sonzogni A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020;20(10):1135&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279758</ArticleId><ArticleId IdType="pubmed">32526193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, et al. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med 2022;20(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 2021;12(1):5417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund O, Breslavsky A, et al. Interactions and clinical implications of serological and respiratory variables 3 months after acute COVID-19. Clin Exp Med 2023;23(7):3729&#x2013;3736.</Citation><ArticleIdList><ArticleId IdType="pubmed">37479879</ArticleId></ArticleIdList></Reference><Reference><Citation>Tor&#xe9;n K, Schi&#xf6;ler L, et al. Restrictive spirometric pattern and true pulmonary restriction in a general population sample aged 50 &#x2013; 64 years. BMC Pulm Med 2020;20(1):55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7045734</ArticleId><ArticleId IdType="pubmed">32106839</ArticleId></ArticleIdList></Reference><Reference><Citation>Furmanek SPG, Chandler T, et al. The City of Louisville Encapsulates the United States Demographics. The University of Louisville Journal of Respiratory Infections. 2020;4(2).</Citation></Reference><Reference><Citation>Hockele LF, Sachet Affonso JV, et al. Pulmonary and Functional Rehabilitation Improves Functional Capacity, Pulmonary Function and Respiratory Muscle Strength in Post COVID-19 Patients: Pilot Clinical Trial. Int J Environ Res Public Health. 2022;19(22).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9691070</ArticleId><ArticleId IdType="pubmed">36429613</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>